BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11571641)

  • 1. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
    Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
    Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
    Knoepfler PS; Kamps MP
    Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
    Lu Q; Kamps MP
    Oncogene; 1997 Jan; 14(1):75-83. PubMed ID: 9010234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
    Kamps MP; Wright DD
    Oncogene; 1994 Nov; 9(11):3159-66. PubMed ID: 7936638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
    Kamps MP; Wright DD; Lu Q
    Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8.
    Wang GG; Calvo KR; Pasillas MP; Sykes DB; Häcker H; Kamps MP
    Nat Methods; 2006 Apr; 3(4):287-93. PubMed ID: 16554834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
    Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
    Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
    Aulisa L; Forraz N; McGuckin C; Hartgerink JD
    Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
    Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
    Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
    Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
    Miranda MB; Xu H; Torchia JA; Johnson DE
    Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
    Calvo KR; Sykes DB; Pasillas M; Kamps MP
    Mol Cell Biol; 2000 May; 20(9):3274-85. PubMed ID: 10757811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
    Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
    Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
    Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
    Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOX cofactors expression and regulation in the human ovary.
    Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
    Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.
    Chang CP; Jacobs Y; Nakamura T; Jenkins NA; Copeland NG; Cleary ML
    Mol Cell Biol; 1997 Oct; 17(10):5679-87. PubMed ID: 9315626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.